A infertilidade feminina devido ao defeito da zona pelúcida é um distúrbio genético raro da infertilidade feminina, caracterizado pela presença de oócitos anormais sem zona pelúcida. Os indivíduos afetados são incapazes de conceber, apesar de terem ciclos menstruais e níveis de hormônios sexuais normais, bem como não terem obstruções nas trompas de falópio ou defeitos no útero ou anexos.
Introdução
O que você precisa saber de cara
A infertilidade feminina por anomalias da zona pelúcida é uma condição genética rara em que os óvulos da mulher não formam a membrana que os envolve. As mulheres com essa alteração têm menstruações normais e hormônios equilibrados, mas não conseguem engravidar naturalmente. O problema está ligado a mudanças em genes como o ZP1, ZP2 e ZP3, que comandam a estrutura do óvulo. Não há remédio específico dispensado pelo SUS e a condição não possui um protocolo oficial (PCDT) no Ministério da Saúde.
A infertilidade feminina devido ao defeito da zona pelúcida é um distúrbio genético raro da infertilidade feminina, caracterizado pela presença de oócitos anormais sem zona pelúcida. Os indivíduos afetados são incapazes de conceber, apesar de terem ciclos menstruais e níveis de hormônios sexuais normais, bem como não terem obstruções nas trompas de falópio ou defeitos no útero ou anexos.
Tem tratamento?
Escala de raridade
<1/50kMuito rara
1/20kRara
1/10kPouco freq.
1/5kIncomum
1/2k
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 4 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
3 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive.
Curadoria gene-doença
fontes oficiaisOocyte/zygote/embryo maturation arrest 6
An autosomal recessive infertility disorder characterized by oocyte fertilization failure, due to defective sperm-binding to an abnormally thin zona pellucida in patient oocytes.
Oocyte/zygote/embryo maturation arrest 3
An autosomal dominant infertility disorder characterized by abnormal oocytes that lack the zona pellucida, and oocytes degeneration.
Oocyte/zygote/embryo maturation arrest 1
An autosomal recessive infertility disorder caused by defective oocyte maturation that results in abnormal eggs lacking a zona pellucida. Affected females have normal menstrual cycles and sex hormone levels, no obstruction in the fallopian tubes or abnormalities of the uterus or adnexa.
Variantes genéticas (ClinVar)
71 variantes patogênicas registradas no ClinVar.
Classificação de variantes (ClinVar)
Distribuição de 15 variantes classificadas pelo ClinVar.
Vias biológicas (Reactome)
1 via biológica associada aos genes desta condição.
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Infertilidade feminina por anomalias da zona pelúcida
Centros de Referência SUS
24 centros habilitados pelo SUS para Infertilidade feminina por anomalias da zona pelúcida
Centros para Infertilidade feminina por anomalias da zona pelúcida
Detalhes dos centros
Hospital Universitário Prof. Edgard Santos (HUPES)
R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808
Serviço de Referência
Hospital Infantil Albert Sabin
R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876
Serviço de Referência
Hospital de Apoio de Brasília (HAB)
AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456
Serviço de Referência
Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)
Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207
Serviço de Referência
Hospital das Clínicas da UFG
Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424
Serviço de Referência
Hospital Universitário da UFJF
R. Catulo Breviglieri, Bairro - s/n - Santa Catarina, Juiz de Fora - MG, 36036-110 · CNES 2297442
Atenção Especializada
Hospital das Clínicas da UFMG
Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167
Serviço de Referência
Hospital Universitário Julio Müller (HUJM)
R. Luis Philippe Pereira Leite, s/n - Alvorada, Cuiabá - MT, 78048-902 · CNES 2726092
Atenção Especializada
Hospital Universitário João de Barros Barreto
R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878
Serviço de Referência
Hospital Universitário Lauro Wanderley (HULW)
R. Tabeliao Estanislau Eloy, 585 - Castelo Branco, João Pessoa - PB, 58050-585 · CNES 0002470
Atenção Especializada
Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)
R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647
Serviço de Referência
Hospital Pequeno Príncipe
R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805
Serviço de Referência
Hospital Universitário Regional de Maringá (HUM)
Av. Mandacaru, 1590 - Parque das Laranjeiras, Maringá - PR, 87083-240 · CNES 2216108
Atenção Especializada
Hospital de Clínicas da UFPR
R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980
Serviço de Referência
Hospital Universitário Pedro Ernesto (HUPE-UERJ)
Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221
Serviço de Referência
Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)
Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988
Serviço de Referência
Hospital São Lucas da PUCRS
Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928
Serviço de Referência
Hospital de Clínicas de Porto Alegre (HCPA)
Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601
Serviço de Referência
Hospital Universitário da UFSC (HU-UFSC)
R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356
Serviço de Referência
Hospital das Clínicas da FMUSP
R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485
Serviço de Referência
Hospital de Base de São José do Rio Preto
Av. Brg. Faria Lima, 5544 - Vila Sao Jose, São José do Rio Preto - SP, 15090-000 · CNES 2079798
Atenção Especializada
Hospital de Clínicas da UNICAMP
R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223
Serviço de Referência
Hospital de Clínicas de Ribeirão Preto (HCRP-USP)
R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187
Serviço de Referência
UNIFESP / Hospital São Paulo
R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689
Serviço de Referência
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Pesquisa e ensaios clínicos
Nenhum ensaio clínico registrado para esta condição.
Publicações mais relevantes
ADAM5 is required for sperm-zona pellucida binding and sperm oviduct migration†.
ADAM5 is a testis-specific transmembrane protein whose role in male fertility remains poorly understood. In this study, we report that Adam5 knockout (KO) male mice are severely subfertile, despite exhibiting normal testicular morphology, sperm structure, and motility. Adam5 KO sperm failed to transit the uterotubal junction (UTJ) and displayed severe defects in zona pellucida (ZP) binding, phenotypes that resemble those observed in Adam2 and Adam3 knockout mice. Western blot analysis revealed a significant reduction in the levels of ADAM2 and ADAM3 in Adam5 KO spermatozoa, supporting the previous finding that ADAM5 interacts with these proteins to form a complex. Additionally, Adam5 KO spermatozoa exhibited reduced binding to extracellular matrix (ECM) components, including Laminin I and Fibronectin. These findings suggest that ADAM5 plays a crucial role in sperm ECM interaction, a process likely critical for successful UTJ transit and ZP binding. While ADAM5 is a pseudogene in humans, our results provide valuable insights into the function of ADAM family proteins in mammalian reproduction.
GALNTL5 binds GalNAc and is required for migration through the uterotubal junction and sperm-zona pellucida binding.
More than 20 genes expressed in the male reproductive tract have been identified as essential factors for sperm migration to and through the utero-tubal junction (UTJ), and they are divided into ADAM3-dependent and ADAM3-independent pathways. In parallel, sperm having UTJ migration defects also show impaired binding to the zona pellucida (ZP). Herein, we demonstrate that knockout of Galntl5, encoding a sperm surface protein, causes impaired sperm binding with the UTJ and ZP, and null males have severe infertility. GALNTL5 appreciably disappears in sperm lacking Adam3 or Lypd4, required for ADAM3-dependent and ADAM3-independent pathways, and GALNTL5 binds to N-acetylgalactosamine (GalNAc) distributed on the UTJ and ZP. Blockage of GalNAc decreases the number of sperm binding to the UTJ and ZP. Thus, we unveil that GALNTL5 is a responsible factor for UTJ migration and sperm-ZP binding, and that sperm bind to the UTJ and ZP through interaction of GALNTL5 and GalNAc.
Human oocyte quality and reproductive health.
Declining female fertility is a health issue that has received broad global attention. Oocyte quality is the key limiting factor of female fertility, and key processes affecting oocyte quality involve the secretion of and response to hormones, ovarian function, oogenesis, oocyte maturation, and meiosis. However, compared with other species, the research and understanding of human oocyte quality and human reproductive health is limited. This review highlights our current understanding of the physiological factors and pathological factors related to human oocyte quality and discusses potential treatments. In terms of physiology, we discuss the regulation of the hypothalamic-pituitary-gonadal axis, granulosa cells, key subcellular structures, maternal mRNA homeostasis, the extracellular matrix, the maternal microenvironment, and multi-omics resources related to human oocyte quality. In terms of pathology, we review hypothalamic-pituitary-gonadal defects, ovarian dysfunction (including premature ovarian insufficiency and polycystic ovary syndrome), human oocyte development defects, and aging. In terms of the pathological aspects of human oocyte development and quality defects, nearly half of the reported pathogenic genes are involved in meiosis, while the remainder are involved in maternal mRNA regulation, the subcortical maternal complex, zona pellucida formation, ion channels, protein transport, and mitochondrial function. Furthermore, we outline the emerging scientific prospects and challenges for future explorations of the biological mechanisms behind infertility and the development of clinical treatments. This review seeks to deepen our understanding of the mechanisms regulating human oocyte quality and to provide novel insights into clinical female infertility characterized by defects in oocyte quality and oocyte development.
A Compound Heterozygous Pathogenic Variant in ZP2 Gene Causes Female Infertility.
The oocyte maturation defect 6 is an autosomal recessive hereditary disease caused by a homozygous variant in ZP2 gene. It is characterized by female primary infertility due to an abnormally thin zona pellucida (ZP) and defective sperm binding. Here we identified a compound heterozygous variant (c.1924C > T and c.1695-2A > G) in ZP2 gene in a Chinese Han family. Quantitative real-time PCR showed that the variant c.1924C > T significantly decreased the expression of truncated ZP2 message RNA by the nonsense-mediated decay pathway. Minigene assays showed the c.1695-2A > G variant led to an extra-61-nt preservation of intron 15 at the junction between exons 15 and 16 during transcription. Both variants (c.1924C > T and c.1695-2A > G) resulted in truncated ZP2 proteins (p.R642X and p.C566Hfs*2) that lost the transmembrane domain, which prevented the secretion of the mutant ZP2 proteins and produced a structurally abnormal ZP, thus resulting in female infertility. This study further elucidated the pathogenic mechanism of these two variants and provided new support for the genetic diagnosis of female infertility.
Furin-Mediated Cleavage of Zona Pellucida Proteins Is Essential for Oocyte Development.
Zona pellucida (ZP) proteins, essential for oocyte development, undergo posttranslational regulation through furin-mediated cleavage. Nevertheless, our understanding of the functional significance of furin-mediated cleavage of ZP proteins in female reproduction remains limited. Here, using mouse models with disrupted furin cleavage sites in ZP1, ZP2, and ZP3, we found that loss of the furin site in ZP2 caused female infertility associated with empty follicle syndrome (EFS), manifested by the failure to retrieve oocytes after ovarian hyperstimulation. In contrast, female mice carrying cleavage-resistant variants at the furin sites of ZP1 and ZP3 exhibited defective ZP in a subset of oocytes, leading to reduced fecundity. Mechanistically, disruption of the furin cleavage site in ZP2 impaired the transmembrane transport of the non-cleaved ZP2 protein and subsequently reduced the levels of SNARE proteins, ultimately triggering oocyte apoptosis through activation of the p53 and PI3K signaling pathways. Collectively, we uncovered the essential role of furin-mediated cleavage of ZP proteins in female fertility and provided new mechanistic insights into the pathogenesis of EFS. These findings open new avenues for investigating the contribution of posttranslational modifications to female reproduction and for developing potential therapeutic strategies to treat female infertility.
Publicações recentes
ADAM5 is required for sperm-zona pellucida binding and sperm oviduct migration†.
Zona-free blastocyst transfers have significantly lower pregnancy and live birth rates compared to zona-intact blastocysts.
GALNTL5 binds GalNAc and is required for migration through the uterotubal junction and sperm-zona pellucida binding.
Abnormal zona pellucida and follicular development in ZP1-mutant macaques.
Genetic variations in zona pellucida glycoproteins: Implications for fertility and ART outcomes.
📚 EuropePMCmostrando 48
Furin-Mediated Cleavage of Zona Pellucida Proteins Is Essential for Oocyte Development.
MedCommADAM5 is required for sperm-zona pellucida binding and sperm oviduct migration†.
Biology of reproductionGALNTL5 binds GalNAc and is required for migration through the uterotubal junction and sperm-zona pellucida binding.
Nature communicationsGenetic variations in zona pellucida glycoproteins: Implications for fertility and ART outcomes.
Mutation research. Reviews in mutation researchImproving sperm selection strategies for assisted reproduction through closing the knowledge gap in sperm maturation mechanics.
Human reproduction openHuman oocyte quality and reproductive health.
Science bulletinDefects in mRNA splicing and implications for infertility: a comprehensive review and in silico analysis.
Human reproduction updateAssociation of Zona Pellucida Gene Variants With Female Infertility: A Retrospective Genetic Analysis.
BJOG : an international journal of obstetrics and gynaecologyAdvances in Molecular Biology and Immunology of Spermatozoa and Fertilization in Domestic Animals: Implications for Infertility and Assisted Reproduction.
Current molecular medicineA Compound Heterozygous Pathogenic Variant in ZP2 Gene Causes Female Infertility.
Reproductive sciences (Thousand Oaks, Calif.)Summer versus winter: the impact of the seasons on oocyte quality in in vitro fertilization cycles.
Revista da Associacao Medica Brasileira (1992)CALR3 defects disrupt sperm-zona pellucida binding in humans: new insights into male factor fertilization failure and relevant clinical therapeutic approaches.
Human reproduction (Oxford, England)ZP1-Y262C mutation causes abnormal zona pellucida formation and female infertility in humans.
Frontiers in geneticsThe effect of laser-assisted hatching on vitrified/warmed blastocysts: the ALADDIN randomized controlled trial.
Fertility and sterilityGene-knockout by iSTOP enables rapid reproductive disease modeling and phenotyping in germ cells of the founder generation.
Science China. Life sciencesChronological age enhances aging phenomena and protein nitration in oocyte.
Frontiers in endocrinologyAdenylate kinase 9 is essential for sperm function and male fertility in mammals.
Proceedings of the National Academy of Sciences of the United States of AmericaA heterozygous ZP2 mutation causes zona pellucida defects and female infertility in mouse and human.
iScienceIdentification of zona pellucida defects revealed a novel loss-of-function mutation in ZP2 in humans and rats.
Frontiers in endocrinologyOpening the black box: why do euploid blastocysts fail to implant? A systematic review and meta-analysis.
Human reproduction updateBi-allelic variants in ASTL cause abnormal fertilization or oocyte maturation defects.
Human molecular geneticsNovel variants in ZP1, ZP2 and ZP3 associated with empty follicle syndrome and abnormal zona pellucida.
Reproductive biomedicine onlineHealthy birth in a case of total globozoospermia after intracytoplasmic sperm injection and assisted oocyte activation.
Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologieEmbryological Characteristics of Human Oocytes With Agar-Like Zona Pellucida and Its Clinical Treatment Strategy.
Frontiers in endocrinologyA recurrent ZP1 variant is responsible for oocyte maturation defect with degenerated oocytes in infertile females.
Clinical geneticsIdentification of a heterozygous variant of ZP2 as a novel cause of empty follicle syndrome in humans and mice.
Human reproduction (Oxford, England)The conserved fertility factor SPACA4/Bouncer has divergent modes of action in vertebrate fertilization.
Proceedings of the National Academy of Sciences of the United States of AmericaMutations in ZP4 are associated with abnormal zona pellucida and female infertility.
Journal of clinical pathologyMolecular genetics of infertility: loss-of-function mutations in humans and corresponding knockout/mutated mice.
Human reproduction updateUnique morphological characteristics in the ovary of cotton rat (Sigmodon hispidus).
The Journal of reproduction and developmentDPAGT1-Mediated Protein N-Glycosylation Is Indispensable for Oocyte and Follicle Development in Mice.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)Novel biallelic loss-of-function variants in ZP1 identified in an infertile female with empty follicle syndrome.
Journal of assisted reproduction and geneticsMutation of rat Zp2 causes ROS-mediated oocyte apoptosis.
Reproduction (Cambridge, England)Prss55 but not Prss51 is required for male fertility in mice†.
Biology of reproductionHomozygous Splice Site Mutation in ZP1 Causes Familial Oocyte Maturation Defect.
GenesZP1 mutations are associated with empty follicle syndrome: evidence for the existence of an intact oocyte and a zona pellucida in follicles up to the early antral stage. A case report.
Human reproduction (Oxford, England)Influence of mouse defective zona pellucida in folliculogenesis on apoptosis of granulosa cells and developmental competence of oocytes†.
Biology of reproductionNovel mutations in ZP1, ZP2, and ZP3 cause female infertility due to abnormal zona pellucida formation.
Human geneticsTranscriptome analysis of rhesus monkey failed-to-mature oocytes: deficiencies in transcriptional regulation and cytoplasmic maturation of the oocyte mRNA population.
Molecular human reproductionZP2 pathogenic variants cause in vitro fertilization failure and female infertility.
Genetics in medicine : official journal of the American College of Medical GeneticsThe influence of ovarian hyperstimulation drugs on morphometry and morphology of human oocytes in ICSI program.
Taiwanese journal of obstetrics & gynecologyThe protective role of melatonin in porcine oocyte meiotic failure caused by the exposure to benzo(a)pyrene.
Human reproduction (Oxford, England)Detrimental effects of endometriosis on oocyte morphology in intracytoplasmic sperm injection cycles: a retrospective cohort study.
Gynecological endocrinology : the official journal of the International Society of Gynecological EndocrinologyCharacterization of a novel role for the dynamin mechanoenzymes in the regulation of human sperm acrosomal exocytosis.
Molecular human reproductionNovel zona pellucida gene variants identified in patients with oocyte anomalies.
Fertility and sterilityFertilization defects in sperm from Cysteine-rich secretory protein 2 (Crisp2) knockout mice: implications for fertility disorders.
Molecular human reproductionNovel characterization of the HSPA2-stabilizing protein BAG6 in human spermatozoa.
Molecular human reproductionStudy on the zona pellucida 4 (ZP4) gene sequence and its expression in the ovaries of patients with polycystic ovary syndrome.
Journal of endocrinological investigationAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Infertilidade feminina por anomalias da zona pelúcida.
É de uma associação que acompanha esta doença? Fale com a gente →
Doença com base genética
Um médico geneticista pode ajudar no diagnóstico de Infertilidade feminina por anomalias da zona pelúcida e no aconselhamento genético da família.
Doenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Perguntas frequentes
O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu
A condição é causada por variantes genéticas nos genes ZP1, ZP2 ou ZP3. Esses genes são responsáveis pelas glicoproteínas que formam a camada protetora externa dos óvulos.
Referências
Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete
8 publicações do grafo RarasNet (PubMed) · 7 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Citar este verbete
Raras. (s.d.). Infertilidade feminina por anomalias da zona pelúcida. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/infertilidade-feminina-por-anomalias-da-zona-pelucida
Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
Infertilidade feminina por anomalias da zona pelúcida
📋 Origem dos dados
Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.
- Doença rara (ontologia)
- fonte: Orphanet
- Identificador unificado
- fonte: MONDO
- Genética mendeliana
- fonte: OMIM
- Codificação WHO/SUS
- fonte: WHO ICD-10 / DATASUS
- CID-11 (futuro)
- fonte: WHO ICD-11
- NIH/GARD
- fonte: GARD (NIH)
- Dado público estruturado
- fonte: Wikidata
- Reposicionamento
- fonte: Drug Repurposing Hub